Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September, 2026
Filed with HKEX · Stock code 1541 · · 11 pages · English
ImmuneOnco Biopharmaceuticals (Shanghai) Inc on 6ix
Earlier from ImmuneOnco Biopharmaceuticals (Shanghai)
- Next Day Disclosure Return
- Voluntary announcement - completion of capital Increase of a subsidiary
- 2026 Interim Report
- Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
- Instil Bio Announces ImmuneOnco’s Presentation of ‘2510 Monotherapy Data in Patients with 2L+ Squamous NSCLC at the 2025 World Conference on Lung Cancer (WCLC)
Follow ImmuneOnco Biopharmaceuticals (Shanghai) into a list and get an email when it puts out news.
Follow ImmuneOnco Biopharmaceuticals (Shanghai)